...
机译:
Merck & Co Inc, MRL, Dept Discovery Chem, Rahway, NJ 07065 USA;
机译:Mitigating a Bioactivation Liability with an Azetidine-Based Inhibitor of Diacylglycerol Acyltransferase 2 (DGAT2) En Route to the Discovery of the Clinical Candidate Ervogastat
机译:Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis
机译:A Review on Recent Robotic and Analytic Technologies in High-Throughput Screening and Synthesis for Drug Discovery
机译:Harnessing DNa-Based Technology for Drug Discovery